Abstract
Background and Purpose
Recent data have shown that the hemostatic system may play a role in cancer development and progression. To test whether factor VII (FVII) can be a candidate factor for breast cancer, we have evaluated the distribution of FVII gene polymorphisms in breast cancer patients and healthy subjects.
Methods
The nested case–control study consisted of 92 women with breast cancer (group 1) and 80 control subjects (in age-matched women) (group 2). Genotyping of the −323ins10-bp, −401GT, and −402GA polymorphisms of the FVII gene was performed by the method of single-strand conformation polymorphism analysis and sequencing.
Results
A significant difference was observed in the distribution of the −402GA genotype and allele frequencies in breast cancer and control cases (p < 0.05). For other polymorphisms of the FVII gene, the distributions of genotypes and allele frequencies were not significantly different between two groups (p > 0.05). There was also a significant difference between the distributions of the haplotypes in breast cancer patients and control subjects (p < 0.05).
Conclusion
Although the number of cases in this study was small, the preliminary findings revealed a possible contribution of the FVII −402GA polymorphism in the development of breast cancer. However, further case–control studies with larger series are needed to confirm our findings.
Similar content being viewed by others
References
Horowitz N, Brenner B. Thrombophilia and cancer. Pathophysiol Haemost Thromb. 2007;36:131–6.
Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest. 2003;124:58S–68S.
Nijziel MR, van Oerle R, Christella M, Thomassen LG, van Pampus EC, Hamulyak K, et al. Acquired resistance o activated protein C in breast cancer patients. Br J Haematol. 2003;120:117–22.
Miller GJ, Bauer KA, Howarth DJ, Cooper JA, Humphries SE, Rosenberg RD. Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. J Thromb Haemost. 2004;2:2107–14.
Sorensen BB, Rao LVM, Tornehave D, Gammeltoft S, Petersen LC. Antiapoptotic effect of coagulation factor VIIa. Blood. 2003;102:1708–15.
Pollak AS, Hung HL, Godin W, Overton GC, High KA. Functional characterization of the human factor VII 5′-flanking region. J Biol Chem. 1996;271:1738–47.
Dell’Acqua G, Iacoviello L, D’Orazio A, Di Bitondo R, Di Castelnuovo A, Donati MB. A polymorphic cluster in the 5′-region of the human coagulation factor VII gene: detection, frequency, and linkage disequilibrium. Thromb Res. 1997;88:445–8.
van’t Hooft FM, Silveira A, Tornvall P, Iliadou A, Ehrenborg E, Eriksson P, et al. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood. 1999;93:3432–41.
Lievers KJA, Mennen LI, Rattink AP, Zwinderman AH, Jukema JW, Schouten EG, et al. The −323ins10 polymorphism for factor VII is not associated with coronary atherosclerosis in symptomatic men. Thromb Res. 2000;97:275–80.
Korte W. Changes of the coagulation and fibrinolysis system in malignancy: their possible impact on future diagnostic and therapeutic procedures. Clin Chem Lab Med. 2000;38:679–92.
Francis JL, Amirkhosravi A. Effect of antihemostatic agents on experimental tumor dissemination. Semin Thromb Hemost. 2002;28:29–38.
Jiang X, Bailly MA, Panetti TS, Cappello M, Konigsberg WH, Bromberg ME. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells. J Thromb Haemost. 2004;2:93–101.
Hu Z, Garen A. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc Natl Acad Sci USA. 2001;98:12180–5.
Iversen LH, Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer. Thromb Haemost. 2002;87:402–8.
Tormene D, Beltramello P, Perlati M, Brandolin B, Barbar S, Toffoli GD, Simioni P. The risk of cancer progression in women with gynecological malignancies and thrombophilic polymorphisms: a pilot case-control study. Clin Appl Thromb Hemost. 2008. doi:10.1177/1076029608317941.
Eroglu A, Çam R, Egin Y, Akar N. Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer. Breast Cancer Res Treat. 2009;116:619–20.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Eroğlu, A., Öztürk, A. & Akar, N. Association between the −402GA, −401GT, and −323ins10-bp polymorphisms of factor VII gene and breast cancer. Breast Cancer 18, 282–285 (2011). https://doi.org/10.1007/s12282-009-0189-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-009-0189-6